TF and gastric cancer: Coming of the opposite character of changes in anti-TF IgM level and the sialylation degree of TF-targeting antibodies in cancer, a combination of these two parameters may be recommended as a novel biomarker for an early diagnosis of gastric cancer and disease prognosis.